We are live on ! Find out more
TGTX icon

TG Therapeutics
TGTX

132 hedge funds and large institutions have $534M invested in TG Therapeutics in 2018 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 36 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

141% more call options, than puts

Call options by funds: $20.8M | Put options by funds: $8.63M

44% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 16

39% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 36

6% more funds holding

Funds holding: 125 → 132 (+7)

1.11% more ownership

Funds ownership: 51.07% → 52.17% (+1.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less capital invested

Capital invested by funds: $548M → $534M (-$13.9M)

Holders
132
Holders Change
+7
Holders Change %
+5.6%
% of All Funds
3.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
50
Reduced
36
Closed
16
Calls
$20.8M
Puts
$8.63M
Net Calls
+$12.2M
Net Calls Change
+$5.15M

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$24.8M
2
Wells Fargo
Wells Fargo
California
+$11.7M
3
BlackRock
BlackRock
New York
+$8.33M
4
State Street
State Street
Massachusetts
+$8.17M
5
OM
Opaleye Management
Massachusetts
+$4.82M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$16M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.57M
3
SAM
Senzar Asset Management
New York
-$6.11M
4
ACA
Avoro Capital Advisors
New York
-$3.85M
5
UBS AM
UBS AM
Illinois
-$3.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$2.82M +$333K +24,234 +13%
Group One Trading
27
Group One Trading
Illinois
$2.6M +$228K +16,572 +9%
EU
28
Emory University
Georgia
$2.57M +$2.69M +195,463 New
Invesco
29
Invesco
Georgia
$2.34M +$2.44M +177,686 New
HP
30
Hikari Power
Japan
$2.1M – – –
Allianz Asset Management
31
Allianz Asset Management
Germany
$2.04M -$12.4K -899 -0.6%
QIM
32
Quantitative Investment Management
Virginia
$1.95M +$447K +32,500 +28%
RJFSA
33
Raymond James Financial Services Advisors
Florida
$1.9M +$71K +5,165 +4%
TCIM
34
TIAA CREF Investment Management
New York
$1.64M +$26.9K +1,958 +2%
TA
35
Teachers Advisors
New York
$1.61M +$141K +10,225 +9%
Deutsche Bank
36
Deutsche Bank
Germany
$1.55M -$939K -68,264 -37%
RJA
37
Raymond James & Associates
Florida
$1.42M -$1.62M -117,735 -52%
Bank of America
38
Bank of America
North Carolina
$1.34M +$964K +70,070 +222%
Citigroup
39
Citigroup
New York
$1.31M +$96.4K +7,013 +8%
GH
40
GAM Holding
Switzerland
$1.3M – – –
Swiss National Bank
41
Swiss National Bank
Switzerland
$1.26M – – –
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$1.22M -$190K -13,800 -13%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$1.19M +$170K +12,340 +16%
Man Group
44
Man Group
United Kingdom
$1.05M +$1.1M +80,250 New
EP
45
Eversept Partners
New York
$1.05M -$963K -70,000 -47%
ARTA
46
A.R.T. Advisors
New York
$1.03M +$1.08M +78,652 New
Federated Hermes
47
Federated Hermes
Pennsylvania
$982K +$235K +17,104 +30%
NC
48
Nexthera Capital
New York
$949K +$993K +72,200 New
MWP
49
MYCIO Wealth Partners
Pennsylvania
$923K +$965K +70,200 New
Macquarie Group
50
Macquarie Group
Australia
$889K +$211K +15,377 +29%
1
2
3 4 5

TGTX Hedge Fund Activity: Q2 2018 in Review

132 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q2 2018, worth a combined $534M — down 2.5% from $548M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new TGTX positions and 16 closed out — a net gain of 7 holders — while 50 added to existing stakes and 36 trimmed.

The largest buyer was RA Capital Management, adding an estimated $24.8M. The largest seller was Fidelity Investments, cutting an estimated $16M.

  • 132 institutional investors held TG Therapeutics (TGTX) as of Q2 2018, up from 125 in Q1 2018.
  • Funds reported $534M of TG Therapeutics stock for Q2 2018, down 2.5% quarter-over-quarter.
  • 23 funds opened new TG Therapeutics positions in Q2 2018 and 16 closed out, a net change of +7 holders.
  • The largest TG Therapeutics buyer in Q2 2018 was RA Capital Management, an estimated $24.8M added.
  • The largest TG Therapeutics seller in Q2 2018 was Fidelity Investments, an estimated $16M sold.

Based on aggregated 13F filings for Q2 2018.